Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

University of Kentucky HealthCare

3 abstracts

Abstract
A phase II randomized control trial of triapine plus lutetium 177 DOTATATE versus lutetium 177 DOTATATE alone for well-differentiated somatostatin receptor-positive neuroendocrine tumors.
Org: Markey Cancer Center, University of Kentucky HealthCare,
Abstract
Sociodemographic factors affecting survival in stage IIIA NSCLC treated with surgery-based treatment or definitive chemoradiation with immunotherapy consolidation: An NCDB analysis.
Org: University of Kentucky HealthCare, Markey Cancer Center, University of Kentucky, University of Kentucky, Lexington, KY, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Johnston Memorial Hospital,
Abstract
Survival outcomes of stage I small cell lung cancer (SCLC) treated with stereotactic body radiation therapy (SBRT) versus external beam radiation therapy (EBRT): An NCDB analysis.
Org: University of Kentucky HealthCare, Markey Cancer Center, University of Kentucky, University of Kentucky, Lexington, KY, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX,